“Voices” – a new home of debate

If you’ve noticed that there haven’t been many posts on the Cancer Blog recently, there is a good reason. We’re now posting in the new “Voices” section of the Cancer World website. Please go and have a look. Like the Cancer Blog, the Voices section provides lively viewpoints and analysis from a wide range of people working in, and affected by, cancer.

This blog began nearly three years ago – a spin-off to the European School of Oncology’s Cancer World magazine. Our aim was to provide a regular showcase for opinion that could lead to the conversation, collaboration and change that is so urgently needed in cancer.

Fifty four posts later, that aim – intrinsic to Cancer World – remains. But in recent years the Cancer World website has grown and flourished, and it now seems entirely appropriate that this should be the home of debate, providing a showcase for cancer voices – whether they belong to doctors, researchers, patients, advocates or policy makers.

So we hope you’ll continue to follow us at our new home – and contribute posts too by emailing us your ideas to staff@cancerworld.net

In order to stay up to date with our posts in “Voices, news from the Cancer World website and details of Cancer World articles we invite you to subscribe to our Cancer World Newsletter. Let the conversation continue…

Risks and benefits – what do we patients have a right to know?

The principle of informed consent is supposed to safeguard our rights as patients to accept or reject a proposed medical treatment on the basis of an understanding about the risks and benefits it offers. There are big variations, however, in how it is put into practice, which may impact on the decisions patients take regarding,… Read More →

Empower people with cancer by talking about dying

“There’s nothing more we can do for you. Go home and get palliative care.” That’s probably not the best way to tell someone that the treatment isn’t working, but that’s how one consultant chose to inform our son, Neil, aged 35, that he wasn’t advocating any more chemotherapy for his sarcoma. Not only was it untrue… Read More →

ProtecT and survival: what do we make of major prostate cancer trial?

It’s a study worthy of headlines, and it got them. The early results of the ProtecT trial have been published – and they’re important if only because this is the first randomised study comparing three common approaches to localised prostate cancer: surgery, radiotherapy and active surveillance. The news stories have been clear on the main… Read More →

A Global License for Breast Surgery – my call to action!

I am a two-time breast cancer survivor. My diseased breast, which had a triple-negative collision tumour, was partially removed and immediately reconstructed with autologous tissue followed by chemotherapy and radiation. Exactly five years later a recurrence was diagnosed and the tumour was successfully removed again. I am lucky to have received top-quality health care. However… Read More →

8

Setting the record straight on cancer research

Cancer research is about testing evidence strenuously and objectively and can’t be judged by innuendo, conspiracy theories and pseudoscience, writes Steve Buist. First things first. I’m not a doctor, and I’m certainly not an oncologist, so do with that information what you wish. I do have a degree in biological science, and I’ve written about… Read More →